Indication
Congenital Afibrinogenemia
1 clinical trial
1 product
Clinical trial
A Prospective, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Human Plasma-derived Fibrinogen Concentrate (FIB Grifols) in Subjects With Congenital Afibrinogenaemia and Severe Hypofibrinogenemia Requiring Either On-demand Treatment for Acute Bleeding or Surgical ProphylaxisStatus: Withdrawn, Estimated PCD: 2025-03-01
Product
FIB Grifols